Sarah Fakih
Thank you. Good morning, good afternoon, and welcome to our conference call. My name is Sarah Fakih. I'm the vice president of investor relations at CureVac.
Please let me introduce today's speakers. On the call with me are Franz Haas, the chief executive officer of CureVac; Pierre Kemula, our chief financial officer; and Ulrike Gnad-Vogt, our interim chief development officer. Mariola Fotin-Mleczek, the CureVac chief technology officer will be available for the Q&A session after the presentation. Please note that this call is being webcast live and will be archived on the events and presentations section under investor relations on our website.